The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which has no cure to date. This disease ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue ...

has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which as no cure to date. This disease causes an aortic aneurysm (an ...

has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which as no cure to date. This disease causes an aortic aneurysm (an ...

The risk of ascending aortic complications including ... that etiology could have a profound impact on aneurysm behavior, with Marfan's syndrome being the prototype. The risk of dissection ...

In people with Marfan's disease, an aneurysm, or ballooning ... who also suffered from Marfan syndrome, to an aortic dissection. "After losing my brother, I really felt like I needed to fight ...

Mitral valve prolapse (MVP) is highly prevalent in Marfan syndrome (MFS), but its associations with significant valvular regurgitation, the need for mitral valve (MV) surgery or elective aortic root ...